13F-HR filed by SECTORAL ASSET MANAGEMENT INC
SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-12, with 64 holding rows worth $968,425,000.
- Accession
- 0001104659-16-139204
- Filer
- CIK 1274413
- Filed
- 2016-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2016
A holdings report, 64 entries on the cover page, a total value of $968,425,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $968,425,000 with VALUE read as thousands by filing date, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,012,206 | $46,005,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 742,960 | $42,802,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 1,192,330 | $41,982,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 529,908 | $41,730,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 416,704 | $41,100,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 476,102 | $39,716,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 1,828,582 | $39,644,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 494,836 | $38,498,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 425,333 | $36,906,000 | thousands by filing date | |
| ABIOMED INC | 003654100 | COM | 298,338 | $32,605,000 | thousands by filing date | |
| ADEPTUS HEALTH | 006855100 | Common Stock | 619,108 | $31,983,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 394,466 | $31,293,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 615,935 | $30,938,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 251,348 | $29,347,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 1,229,382 | $29,013,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 148,424 | $27,322,000 | thousands by filing date | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 480,605 | $26,626,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 4,788,738 | $26,147,000 | thousands by filing date | |
| TELADOC HEALTH INC | 87918A105 | COM | 1,464,221 | $23,457,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 145,095 | $20,487,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 231,575 | $19,920,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 248,459 | $19,872,000 | thousands by filing date | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 246,127 | $19,826,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 522,294 | $17,748,000 | thousands by filing date | |
| MYLAN NV | N59465109 | SHS EURO | 408,170 | $17,649,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 987,224 | $16,378,000 | thousands by filing date | |
| SAGENT PHARMACEUTICALS INC | 786692103 | COM | 1,008,265 | $15,104,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 525,221 | $13,115,000 | thousands by filing date | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 19,274 | $12,748,000 | thousands by filing date | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 216,175 | $11,626,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 166,300 | $9,931,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 54,651 | $7,798,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 152,900 | $7,630,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 146,800 | $7,491,000 | thousands by filing date | |
| AMSURG CORP | 03232P405 | COM | 96,400 | $7,475,000 | thousands by filing date | |
| TEAM HEALTH HOLDINGS INC | 87817A107 | COMMON STOCK | 175,900 | $7,154,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 912,305 | $6,632,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617118 | ORD SHS | 366,975 | $6,374,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 574,040 | $6,200,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 174,746 | $6,109,000 | thousands by filing date | |
| INTEGRA LIFESCIENCES HLDGS C | 457985208 | COM NEW | 60,560 | $4,831,000 | thousands by filing date | |
| SURGICAL CARE AFFILIATES INC COM | 86881L106 | Stock | 98,300 | $4,686,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 648,976 | $4,556,000 | thousands by filing date | |
| ACCURAY INC DEL | 004397105 | COM | 825,875 | $4,286,000 | thousands by filing date | |
| ADVAXIS INC | 007624208 | COM NEW | 433,859 | $3,510,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 294,400 | $3,489,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 367,541 | $3,379,000 | thousands by filing date | |
| ENTELLUS MED INC | 29363K105 | COM | 146,006 | $2,668,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 347,271 | $2,559,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 193,140 | $2,497,000 | thousands by filing date | |
| LANNETT COMPANY INCORPORATED | 516012101 | COM | 102,693 | $2,443,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 104,971 | $1,706,000 | thousands by filing date | |
| DR REDDYS LABS LTD ADR | 256135203 | ADR | 32,155 | $1,647,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 52,250 | $1,574,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 88,400 | $1,556,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 36,100 | $1,512,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 123,159 | $1,466,000 | thousands by filing date | |
| Sierra Oncology, Inc. | 74346L101 | common | 201,660 | $1,359,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 25,672 | $976,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 29,582 | $960,000 | thousands by filing date | |
| CHINA BIOLOGIC PRODUCTS INC | 16938C106 | COMM STK | 5,890 | $626,000 | thousands by filing date | |
| PROFOUND MED CORP | 74319B106 | COM | 541,500 | $605,000 | thousands by filing date | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 20,600 | $598,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 10,000 | $555,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-16-139204 | this filing | 2016-08-12 | acceptance time not in the bulk data set |